Pomalidomide and low-dose dexamethasone improves health-related quality of life and prolongs time to worsening in relapsed/refractory patients with multiple myeloma enrolled in the MM-003 randomized phase III trial

DSpace Repositorium (Manakin basiert)

Pomalidomide and low-dose dexamethasone improves health-related quality of life and prolongs time to worsening in relapsed/refractory patients with multiple myeloma enrolled in the MM-003 randomized phase III trial

Autor(en): Weisel, Katja; Dimopoulos, Meletios; Song, Kevin W.; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Gibson, Craig J.; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus
Tübinger Autor(en):
Weisel, Katja
Erschienen in: Clinical Lymphoma Myeloma & Leukemia (2015), Bd. 15, H. 9, S. 519-530
Verlagsangabe: Cig Media Group
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/j.clml.2015.05.007
ISSN: 2152-2650
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: